Eltrombopag, a second-generation thrombopoietin receptor agonist, for chronic lymphocytic leukemia-associated ITP

Leukemia

Volumn 24, Issue 5, 2010, Pages 1096-1098

  Koehrer, S ^a   Keating, M J ^a   Wierda, W G ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; ELTROMBOPAG; FLUDARABINE; OXALIPLATIN; PREDNISONE; RITUXIMAB;

ADULT; AGED; CANCER STAGING; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; LETTER; LEUKEMIA CELL; LEUKEMIA REMISSION; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; SPLENECTOMY; THROMBOCYTOPENIC PURPURA; TREATMENT RESPONSE;

EID: 77952422869     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2010.45     Document Type: Letter

References (8)

1. Dearden C. Disease-specific complications of chronic lymphocytic leukemia. Hematology 2008; 2008: 450-456.
2. Diehl LF, Ketchum LH. Autoimmune disease and chronic lympho-cytic leukemia: autoimmune hemolytic anemia, pure red cell aplasia, and autoimmune thrombocytopenia. Semin Oncol 1998; 25: 80-97.
3. Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood 2009; 113: 6511-6521.
4. Harrington WJ, Minnich V, Hollingsworth JW, Moore CV. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med 1951; 38: 1-10.
5. Chang M, Nakagawa PA, Williams SA, Schwartz MR, Imfeld KL, Buzby JS et al. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryo-cytopoiesis in vitro. Blood 2003; 102: 887-895.
6. Nurden AT, Viallard J-F, Nurden P. New-generation drugs that stimulate platelet production in chronic immune thrombocytopenic purpura. Lancet 2009; 373: 1562-1569.
7. Bussel JB, Provan D, Shamsi T, Cheng G, Psaila B, Kovaleva L et al. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial. Lancet 2009; 373: 641-648.
8. Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM et al. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial. Lancet 2008; 371: 395-403.